
A multi-disciplinary lab dedicated to ensuring that all people can get the best diabetes preventive practices and treatments, wherever they get their care. We partner with those living with prediabetes, type 1 diabetes, and type 2 diabetes to drive innovations that enhance care.
Primary care patients with type 2 diabetes may be eligible to participate in a study featuring a wearable fitness and activity tracker plus artificial intelligence (AI)-tailored and delivered diabetes self-management education and support.
Email [email protected] for more information.
We currently have two studies featuring different automated insulin delivery systems! Persons with type 2 diabetes may qualify.
Email [email protected] for more information.
People newly diagnosed with type 2 diabetes may be eligible to participate in a study featuring a lifestyle guide combined with a CGM (continuous glucose monitor) and FitBit. The study will determine if people respond better to usual care or to a lifestyle intervention that focuses on reducing how much blood glucose goes up after eating, by minimizing certain foods and increasing routine physical activity.
Now recruiting!
Email [email protected] for more information.
This study will feature an automated insulin delivery pump for persons with insulin-requiring diabetes.
Recruiting soon - Stay tuned!
Email [email protected] for more information.
This study will feature an over the counter CGM.
Recruiting soon - Stay tuned!
Email [email protected] for more information.
Stay tuned!
Email [email protected] for more information.
A research study to compare the effectiveness of a Dexcom G7 CGM with Routine Care (RC) in managing glucose levels in people with type 2 diabetes currently not using insulin.
A research study to determine the feasibility of a system for recommending doses of basal insulin for patients with type 2 diabetes.